Psilocybin in Cancer Pain Study | MicrobiomeTrials← Back to trialsNCT06001749
Psilocybin in Cancer Pain Study
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-23Est. Completion: 2026-10-01
Enrollment target: 15 participants Locations- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Recovery of FunctionPostoperative PeriodCesarean Section
This prospective single-center observational cohort study investigates whether objectively measured early postoperative …
Izmir, Turkey (Türkiye)Est. completion Apr 2027
Substance Use Disorders (SUDs)
Background:
A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses.…
Baltimore, United StatesCompleted May 31, 2027
ENROLLING_BY_INVITATION
BurnoutSecondary TraumaCompassion FatigueOpioid Use DisorderStimulant Use DisorderSubstance Use Disorder
The investigators propose to test the effectiveness of PATH (Peer Advanced Training for total Health) as an educational …
Chicago, United StatesCompleted Mar 2029